Joel Greenblatt's EXAS Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 11,430 shares of Exact Sciences Corporation (EXAS) worth $625,335, representing 0.00% of the portfolio. First purchased in 2016-Q2, this long-term strategic position has been held for 38 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in EXAS, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2017, adding 154,834 shares. Largest reduction occurred in Q4 2017, reducing 121,882 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Exact Sciences Corporation (EXAS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Exact Sciences Corporation (EXAS) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2016 | +17,669 | New Buy | 17,669 | $12.22 |
| Q3 2016 | +35,583 | Add 201.39% | 53,252 | $18.57 |
| Q4 2016 | -53,252 | Sold Out | 53,252 | $0.00 |
| Q1 2017 | +56,048 | New Buy | 56,048 | $23.62 |
| Q2 2017 | +126,037 | Add 224.87% | 182,085 | $35.37 |
| Q3 2017 | +154,834 | Add 85.03% | 336,919 | $47.12 |
| Q4 2017 | -121,882 | Reduce 36.18% | 215,037 | $52.54 |
| Q1 2018 | -86,423 | Reduce 40.19% | 128,614 | $40.33 |
| Q2 2018 | -36,472 | Reduce 28.36% | 92,142 | $59.79 |
| Q3 2018 | -48,316 | Reduce 52.44% | 43,826 | $78.93 |
| Q4 2018 | +221 | Add 0.50% | 44,047 | $63.09 |
| Q1 2019 | +944 | Add 2.14% | 44,991 | $86.62 |
| Q2 2019 | -41,400 | Reduce 92.02% | 3,591 | $118.07 |
| Q3 2019 | -3,591 | Sold Out | 3,591 | $0.00 |
| Q4 2019 | +6,005 | New Buy | 6,005 | $92.42 |
| Q1 2020 | +2,099 | Add 34.95% | 8,104 | $58.00 |
| Q2 2020 | +9 | Add 0.11% | 8,113 | $86.90 |
| Q3 2020 | -1,250 | Reduce 15.41% | 6,863 | $102.00 |
| Q4 2020 | -1,027 | Reduce 14.96% | 5,836 | $132.45 |
| Q1 2021 | -1,134 | Reduce 19.43% | 4,702 | $131.86 |
| Q2 2021 | +33 | Add 0.70% | 4,735 | $124.39 |
| Q3 2021 | +1,940 | Add 40.97% | 6,675 | $95.43 |
| Q4 2021 | +1,815 | Add 27.19% | 8,490 | $77.86 |
| Q1 2022 | -2,398 | Reduce 28.24% | 6,092 | $69.93 |
| Q2 2022 | -6,092 | Sold Out | 6,092 | $0.00 |
| Q3 2022 | +34,861 | New Buy | 34,861 | $32.50 |
| Q4 2022 | +46,059 | Add 132.12% | 80,920 | $49.51 |
| Q1 2023 | -2,086 | Reduce 2.58% | 78,834 | $67.81 |
| Q2 2023 | +11,100 | Add 14.08% | 89,934 | $93.90 |
| Q3 2023 | +4,347 | Add 4.83% | 94,281 | $68.22 |
| Q4 2023 | -27,822 | Reduce 29.51% | 66,459 | $73.98 |
| Q1 2024 | +8,650 | Add 13.02% | 75,109 | $69.06 |
| Q2 2024 | +56,440 | Add 75.14% | 131,549 | $42.25 |
| Q3 2024 | +30,873 | Add 23.47% | 162,422 | $68.12 |
| Q4 2024 | -12,302 | Reduce 7.57% | 150,120 | $56.19 |
| Q1 2025 | -73,541 | Reduce 48.99% | 76,579 | $43.29 |
| Q2 2025 | +32,361 | Add 42.26% | 108,940 | $53.14 |
| Q3 2025 | -97,510 | Reduce 89.51% | 11,430 | $54.71 |
Joel Greenblatt's Exact Sciences Corporation Investment FAQs
Joel Greenblatt first purchased Exact Sciences Corporation (EXAS) in Q2 2016, acquiring 17,669 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Exact Sciences Corporation (EXAS) for 38 quarters since Q2 2016. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to Exact Sciences Corporation (EXAS) was in Q3 2017, adding 336,919 shares worth $15.88 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 11,430 shares of Exact Sciences Corporation (EXAS), valued at approximately $625,335. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Exact Sciences Corporation (EXAS) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in Exact Sciences Corporation (EXAS) was 336,919 shares, as reported at the end of Q3 2017. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.